Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Helix CBD Therapy Cream** is a menthol-based OTC topical analgesic cream developed and manufactured by Parker Laboratories for temporary relief of minor musculoskeletal aches and pains, including those associated with arthritis, simple backache, strains, bruises, sprains, sore muscles, and sore joints. Its labeled analgesic active ingredient is menthol 7.4%, which produces a cooling counterirritant effect. The cream also contains hemp-derived cannabis sativa seed oil with cannabidiol, plus botanical ingredients such as arnica, ilex, and tangerine oil. It is supplied as a topical cream rather than a transdermal product and was sold in 2 oz and 4 oz packages containing 300 mg and 600 mg of cannabidiol, respectively. ([parkerlabs.com](https://www.parkerlabs.com/wp-content/uploads/2023/02/2023-Parker-Laboratories-Pricing-Schedule-02-14-23.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Helix CBD Therapy Cream.